In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synthetic Genomics Inc.

www.syntheticgenomics.com

Latest From Synthetic Genomics Inc.

Venter's Synthetic Genomics Sued For Gender Discrimination

Synthetic Genomics, co-founded by genomic pioneer Craig Venter, has been sued by its former intellectual property chief for gender discrimination – a claim that CEO Oliver Fetzer believes to be "without merit."

Legal Issues Human Capital

Appointments: Sanofi, Regeneron, Galena, Genmab, Abpro and Myokardia

This week's roundup sees Sanofi appoint Biogen's former SVP of corporate affairs to executive vice president, external affairs. Meanwhile, Galena Biopharma, Abpro, Genmab and Purdue Pharma have all named new executives.

Appointments

Synthetic Biology And The Computerization Of Drug Development

Synthetic biology offers opportunity across many industries, but the ultimate prize may be health care. The millions of dollars investors have poured into companies developing CAR-T cell therapies and gene editing technologies points to growing confidence in the power of gene manipulation to generate novel, approvable therapeutics, even if for now these are just the early steps toward creating fully synthetic organisms.

BioPharmaceutical Innovation

Execs On The Move, December 2014

Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.

Medical Device BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Transgenics
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Synthetic Genomics Inc.
  • Senior Management
  • Oliver Fetzer, PhD, CEO
    Joseph Mahler, CFO
    Hamilton O Smith, MD, Co-CSO
    Anthony Artuso, PhD, CBO
    J. Craig Venter, PhD, Co-CSO
    Ben Chiarelli, VP, Corp. Dev. & Strategy
  • Contact Info
  • Synthetic Genomics Inc.
    Phone: (858) 754-2900
    11149 North Torrey Pines Rd.
    La Jolla, CA 92037
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register